Investor Relations

Advanced therapies for the sports medicine and severe burn care markets

Investor Relations

SEC Filing Details

SEC Filing Details

Document Details

Form
Filing Date
Mar 28, 2016
Document Date
Mar 18, 2016
Form Description
Initial filing by director officer or owner of more than ten percent.
Filing Group
3,4,5
Company
Vericel Corporation
Issuer
VERICEL CORP
Filer
BLUTT MITCHELL J MD

Day High:
Day Low:
Volume:
on
Data Provided by Refinitiv. Minimum 15 minutes delayed.